The role of 217-Hz ELF magnetic fields emitted from GSM mobile phones on electrochemotherapy mechanisms

References

• Andersen, J. B., and G. F. Pedersen. 1997. The technology of mobile telephone systems relevant for risk assessment. Radiat. Prot. Dosim. 72:249–57. doi:10.1093/oxfordjournals.rpd.a032097.
   Web of Science ®Google Scholar
• Basile, A., R. Zeppa, N. Pasquino, C. Arra, M. Ammirante, M. Festa, A. Barbieri, A. Giudice, M. Pascale, and M. C. Turco. 2011. Exposure to 50 Hz electromagnetic field raises the levels of the anti‐apoptotic protein BAG3 in melanoma cells. J. Cell. Physiol. 226:2901–07. doi:10.1002/jcp.22641.
   PubMed Web of Science ®Google Scholar
• Benassi, B., G. Filomeni, C. Montagna, C. Merla, V. Lopresto, R. Pinto, C. Marino, and C. Consales. 2016. Extremely low frequency magnetic field (ELF-MF) exposure sensitizes SH-SY5Y cells to the pro-Parkinson’s disease toxin MPP+. Mol. Neurobiol. 53:4247–60. doi:10.1007/s12035-015-9354-4.
   PubMed Web of Science ®Google Scholar
• Burkart, W. 1989. Effect of 3-aminobenzamide on chromosome damage in human blood lymphocytes adapted to bleomycin. Mutagenesis 4:187–89. doi:10.1093/mutage/4.3.187.
   PubMed Web of Science ®Google Scholar
• Calvet, C. Y., D. Famin, F. M. André, and L. M. Mir. 2014. Electrochemotherapy with bleomycin induces hallmarks of immunogenic cell death in murine colon cancer cells. Oncoimmunology 3:e28131. doi:10.4161/onci.28131.
   PubMed Web of Science ®Google Scholar
• Cameron, I. L., M. S. Markov, and W. E. Hardman. 2014. Optimization of a therapeutic electromagnetic field (EMF) to retard breast cancer tumor growth and vascularity. Cancer Cell Int. 14:125. doi:10.1186/s12935-014-0125-5.
   PubMed Web of Science ®Google Scholar
• Cao, Y., and J. Tong. 2014. Adaptive response in animals exposed to non-ionizing radiofrequency fields: Some underlying mechanisms. Int. J. Environ. Res. Public Health 11:4441–48. doi:10.3390/ijerph110404441.
   PubMed Web of Science ®Google Scholar
• Cemazar, M., C. Parkins, A. Holder, D. Chaplin, G. Tozer, and G. Sersa. 2001. Electroporation of human microvascular endothelial cells: Evidence for an anti-vascular mechanism of electrochemotherapy. Br. J. Cancer 84:565. doi:10.1054/bjoc.2000.1625.
   PubMed Web of Science ®Google Scholar
• Council NR. 2010. Guide for the care and use of laboratory animals. Washington (DC): National Academies Press.
   Google Scholar
• Davalos, R. V., L. Mir, and B. Rubinsky. 2005. Tissue ablation with irreversible electroporation. Ann. Biomed. Eng. 33:223. doi:10.1007/s10439-005-8981-8.
   PubMed Web of Science ®Google Scholar
• De Nicola, M., S. Cordisco, C. Cerella, M. C. Albertini, M. D’ALESSIO, A. Accorsi, A. Bergamaschi, A. Magrini, and L. Ghibelli. 2006. Magnetic fields protect from apoptosis via redox alteration. Ann. N. Y. Acad. Sci. 1090:59–68. doi:10.1196/annals.1378.006.
   PubMed Web of Science ®Google Scholar
• Domanico, R., S. Trapasso, M. Santoro, D. Pingitore, and E. Allegra. 2015. Electrochemotherapy in combination with chemoradiotherapy in the treatment of oral carcinomas in advanced stages of disease: Efficacy, safety, and clinical outcomes in a small number of selected cases. Drug Des. Devel. Ther. 9:1185.
   PubMed Web of Science ®Google Scholar
• Entin, I., A. Plotnikov, R. Korenstein, and Y. Keisari. 2003. Tumor growth retardation, cure, and induction of antitumor immunity in B16 melanoma-bearing mice by low electric field-enhanced chemotherapy. Clini. Cancer Res. 9:3190–97.
   PubMed Web of Science ®Google Scholar
• Esmaeili, N., and M. Friebe. 2019. Electrochemotherapy: A review of current status, alternative IGP approaches, and future perspectives. J. Healthc. Eng. 2019:11. doi:10.1155/2019/2784516.
   Web of Science ®Google Scholar
• Fujimoto, T., H. Maeda, K. Kubo, Y. Sugita, T. Nakashima, E. Sato, Y. Tanaka, M. Madachi, M. Aiba, and Y. Kameyama. 2005. Enhanced anti-tumour effect of cisplatin with low-voltage electrochemotherapy in hamster oral fibrosarcoma. J. Int. Med. Res. 33:507–12. doi:10.1177/147323000503300505.
   PubMed Web of Science ®Google Scholar
• Garip, A., and Z. Akan. 2010. Effect of ELF-EMF on number of apoptotic cells; correlation with reactive oxygen species and HSP. Acta. Biol. Hung. 61:158–67. doi:10.1556/ABiol.61.2010.2.4.
   PubMed Web of Science ®Google Scholar
• Gehl, J., T. Skovsgaard, and L. M. Mir. 2002. Vascular reactions to in vivo electroporation: Characterization and consequences for drug and gene delivery. Biochim. Biophys. Acta. Gen. Subj. 1569:51–58. doi:10.1016/S0304-4165(01)00233-1.
   PubMed Web of Science ®Google Scholar
• Huang, K. W., P. C. Yang, U. Pua, M. D. Kim, S. P. Li, Y. D. Qiu, T. Q. Song, and P. C. Liang. 2018. The efficacy of combination of induction chemotherapy and irreversible electroporation ablation for patients with locally advanced pancreatic adenocarcinoma. J. Surg. Oncol. 118:31–36. doi:10.1002/jso.25110.
   PubMed Web of Science ®Google Scholar
• Kotnik, T., P. Kramar, G. Pucihar, D. Miklavcic, and M. Tarek. 2012. Cell membrane electroporation-Part 1: The phenomenon. IEEE Electr. Insul. Mag. 28:14–23. doi:10.1109/MEI.2012.6268438.
   Web of Science ®Google Scholar
• Kunte, C., V. Letule, J. Gehl, K. Dahlstroem, P. Curatolo, R. Rotunno, T. Muir, A. Occhini, G. Bertino, and B. Powell. 2017. Electrochemotherapy in the treatment of metastatic malignant melanoma: A prospective cohort study by InspECT. Br. J. Dermatolo. 176:1475–85. doi:10.1111/bjd.15340.
   PubMed Web of Science ®Google Scholar
• Maglietti, F., M. Tellado, N. Olaiz, S. Michinski, and G. Marshall. 2016. Electrochemotherapy in non-satisfactory responding tumors in vet patients: Combined administration of bleomycin, systemic and local. In 1st world congress on electroporation and pulsed electric fields in biology, medicine and food & environmental technologies, pp. 445–448. Springer, Singapore, 2016.
   Google Scholar
• Mansourian, M., S. M. P. Firoozabadi, Z. Shankayi, and Z. Hassan. 2013. Magnetic fields with frequency of 217 Hz can reduce cell apoptosis caused by electrochemotherapy. Electromagn. Biol. Med. 32:70–78. doi:10.3109/15368378.2012.708693.
   PubMed Web of Science ®Google Scholar
• Markov, M. S. 2010. Angiogenesis, magnetic fields and ‘window effects’. Cardiology 117:54–56. doi:10.1159/000315433.
   PubMed Web of Science ®Google Scholar
• Miklavcic, D., S. Corovic, G. Pucihar, and N. Pavselj. 2006. Importance of tumour coverage by sufficiently high local electric field for effective electrochemotherapy. Eur. J. Cancer Suppl. 4:45–51. doi:10.1016/j.ejcsup.2006.08.006.
   Web of Science ®Google Scholar
• Moghadam, M. K., S. M. Firoozabadi, and M. Janahmadi. 2009. Reduction of F1 neuronal excitability by exposure to 217 Hz magnetic fields from GSM 900 mobile phone. Yakhteh Med. J. 11:176–83.
   Google Scholar
• Mojic, M., K. Takeda, and Y. Hayakawa. 2018. The dark side of IFN-γ: Its role in promoting cancer immunoevasion. Int. J. Mol. Sci. 19:89. doi:10.3390/ijms19010089.
   Web of Science ®Google Scholar
• Niessen, C., E. M. Jung, W. A. Wohlgemuth, B. Trabold, M. Haimerl, A. Schreyer, C. Stroszczynski, and P. Wiggermann. 2013. Irreversible electroporation of a hepatocellular carcinoma lesion adjacent to a transjugular intrahepatic portosystemic shunt stent graft. Korean J. Radiol. 14:797–800. doi:10.3348/kjr.2013.14.5.797.
   PubMed Web of Science ®Google Scholar
• Pucihar, G., J. Krmelj, M. Reberšek, T. B. Napotnik, and D. Miklavčič. 2011. Equivalent pulse parameters for electroporation. IEEE Trans. Biomed. Eng. 58:3279–88. doi:10.1109/TBME.2011.2167232.
   PubMed Web of Science ®Google Scholar
• Ren, H. Y., Y. H. Zhang, H. Y. Li, T. Xie, L. L. Sun, T. Zhu, S. D. Wang, and Z. M. Ye. 2016. Prognostic role of hypoxia-inducible factor-1 alpha expression in osteosarcoma: A meta-analysis. Onco. Targets Ther. 9:1477–87. doi:10.2147/OTT.S95490.
   PubMed Web of Science ®Google Scholar
• Santini, M., A. Ferrante, G. Rainaldi, P. Indovina, and P. Indovina. 2005. Extremely low frequency (ELF) magnetic fields and apoptosis: A review. Int. J. Radiat. Biol. 81:1–11. doi:10.1080/09553000400029502.
   PubMed Web of Science ®Google Scholar
• Sersa, C., M. Cemazar, D. Miklavcic, and D. J. Chaplin. 1999. Tumor blood flow modifying effect of electrochemotherapy with bleomycin. Anticancer Res. 19:4017–22.
   PubMed Web of Science ®Google Scholar
• Sersa, G., T. Jarm, T. Kotnik, A. Coer, M. Podkrajsek, M. Sentjurc, D. Miklavcic, M. Kadivec, S. Kranjc, A. Secerov, et al. 2008a. Vascular disrupting action of electroporation and electrochemotherapy with bleomycin in murine sarcoma. Br. J. Cancer 98:388–98. doi:10.1038/sj.bjc.6604168.
   PubMed Web of Science ®Google Scholar
• Sersa, G., M. Krzic, M. Sentjurc, T. Ivanusa, K. Beravs, V. Kotnik, A. Coer, H. Swartz, and M. Cemazar. 2002. Reduced blood flow and oxygenation in SA-1 tumours after electrochemotherapy with cisplatin. Br. J. Cancer 87:1047. doi:10.1038/sj.bjc.6600606.
   PubMed Web of Science ®Google Scholar
• Sersa, G., D. Miklavcˇicˇ, M. Cemazar, J. Belehradek Jr, T. Jarm, and L. M. Mir. 1997. Electrochemotherapy with CDDP on LPB sarcoma: Comparison of the anti-tumor effectiveness in immunocompetent and immunodeficient mice. Bioelectrochem. Bioenerg. 43:279–83. doi:10.1016/S0302-4598(96)05194-X.
   Web of Science ®Google Scholar
• Sersa, G., D. Miklavcic, M. Cemazar, Z. Rudolf, G. Pucihar, and M. Snoj. 2008b. Electrochemotherapy in treatment of tumours. Eur. J. Surgical Oncol. 34:232–40. doi:10.1016/j.ejso.2007.05.016.
   PubMed Web of Science ®Google Scholar
• Seršaa, G., M. Čemažar, V. Menart, V. Gaberc-Porekar, and D. Miklavčič. 1997. Anti-tumor effectiveness of electrochemotherapy with bleomycin is increased by TNF-α on SA-1 tumors in mice. Cancer Lett. 116:85–92. doi:10.1016/S0304-3835(97)00170-5.
   PubMed Web of Science ®Google Scholar
• Shankayi, Z., S. Firoozabadi, and Z. S. Hassan. 2014. Optimization of electric pulse amplitude and frequency in vitro for low voltage and high frequency electrochemotherapy. J. Membr. Biol. 247:147–54. doi:10.1007/s00232-013-9617-9.
   PubMed Web of Science ®Google Scholar
• Tian, F., T. Nakahara, M. Yoshida, N. Honda, H. Hirose, and J. Miyakoshi. 2002. Exposure to power frequency magnetic fields suppresses X-ray-induced apoptosis transiently in Ku80-deficient xrs5 cells. Biochem. Biophys. Res. Commun. 292:355–61. doi:10.1006/bbrc.2002.6661.
   PubMed Web of Science ®Google Scholar
• Vernole, P., B. Tedeschi, D. Caporossi, M. Maccarrone, G. Melino, and M. Annicchiarico-Petruzzelli. 1998. Induction of apoptosis by bleomycin in resting and cycling human lymphocytes. Mutagenesis 13:209–15. doi:10.1093/mutage/13.3.209.
   PubMed Web of Science ®Google Scholar
• Wang, Y., J. Zhou, S. Fu, C. Wang, and B. Zhou. 2015. A study of association between oral lichen planus and immune balance of Th1/Th2 cells [journal article]. Inflammation 38:1874–79. doi:10.1007/s10753-015-0167-4.
   PubMed Web of Science ®Google Scholar
• Williams, C. D., M. S. Markov, W. E. Hardman, and I. L. Cameron. 2001. Therapeutic electromagnetic field effects on angiogenesis and tumor growth. Anticancer Res.;21(6A):3887–91.
   Google Scholar
• Yao, C., Y. Lv, S. Dong, Y. Zhao, and H. Liu. 2017. Irreversible electroporation ablation area enhanced by synergistic high-and low-voltage pulses. PLoS ONE 12:e0173181. doi:10.1371/journal.pone.0173181.
   PubMed Web of Science ®Google Scholar